170401 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving growth factors Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
BIOMARKERS
#2METHOD FOR ASSESSING DIFFERENTIATION POTENTIAL OF CELLS IN CULTURE BROTH IN DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO NEURAL CELLS OF MIDBRAIN FLOOR PLATE REGION
#3PROTEIN BIOMARKER AND USES THEREOF
#4MAGNETIC POINT-OF-CARE SYSTEMS AND ASSAYS FOR DETERMINING GFAP IN BIOLOGICAL SAMPLES
#5Cell Lines Secreting Alpha-Synuclein Targeting Antibodies, Progranulin and Prosaposin and a Complex of Both, and GDNF
#6Therapeutic Protein Formulations
#7USE OF PROBDNF REGULATOR IN B CELL-RELATED DISEASES
#8METHODS FOR TREATING CARDIAC INJURY
#9METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS
#10NEUKINASE, A DOWNSTREAM PROTEIN OF NEUREGULIN
#11Protein biomarker and uses thereof
#12PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO ANTI-LPS IMMUNOGLOBULIN TREATMENT
#13METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#14Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
#15Use of a Neuregulin to Treat Peripheral Nerve Injury
#16METHODS FOR TREATING CARDIAC INJURY
#17Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#18Method for achieving desired glial growth factor 2 plasma levels
#19METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#20METHODS OF MEASURING ERBB SIGNALING PATHWAY ACTIVITY TO DIAGNOSE AND TREAT CANCER PATIENTS
#21Neukinase, a downstream protein of neuregulin
#22PROTEIN BIOMARKER AND USES THEREOF
#23Method for achieving desired glial growth factor 2 plasma levels
#24Neuregulin variants and methods of screening and using thereof
#25HER2 polypeptides useful for imaging and monitoring tumors and cancers
#26PROTEIN BIOMARKER AND USES THEREOF
#27Method for predicting the response to HER2-directed therapy
#28NEUREGULIN ISOFORMS, NEUREGULIN POLYPEPTIDES AND USES THEREOF
#29METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#30Neuregulin-1-based prognosis and therapeutic stratification of colorectal cancer
#31Neuregulin variants and methods of screening and using thereof
#32METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2
#33Methods for diagnosing heart failure and other cardiac diseases
#34NEUREGULIN/ERBB SIGNALING AND INTEGRIN
#35Method for predicting the response to HER2-directed therapy
#36Use of a neuregulin to treat peripheral nerve injury
#37Treating Negative Symptoms of Schizophrenia Associated with Defective Neuregulin 1
#38METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT
#39Method for achieving desired glial growth factor 2 plasma levels
#40Neuregulin variants and methods of screening and using thereof
#41Neukinase, a downstream protein of neuregulin
#42Materials and Methods for Modulating Cell Motility
#43Cardiac muscle function and manipulation
#44Neuregulin variants and methods of screening and using thereof
#45Cardiac muscle function and manipulation
#46Neuregulin protein regulation of synaptic proteins
#47Method for predicting the response to a treatment
#48Cardiac muscle function and manipulation
#49Cardiac muscle function and manipulation
#50Compositions and methods for treating female fertility
#51Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
#52Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#53Persephin specific antibodies
#54Stimulation of nerve cell regeneration
#55Compositions and methods for treating female fertility
#56Prognostic evaluation of cancer